There is no approved vaccine to curb the Ebola outbreak in the Democratic Republic of the Congo and Uganda. But new funding ...

The global health community is locked in an urgent race against time as an Ebola epidemic continues to surge across Africa.

The University of Cambridge and the company DIOSynVax have completed the human clinical trial of a universal coronavirus ...

The Bundibugyo virus, a little known type, previously had caused just two small outbreaks. Now it’s at the center of a ...

There is an effective vaccine for Ebola — but not for the variety spreading rapidly in the Democratic Republic of Congo.

But these events also serve as a reminder that outbreaks are rarely controlled by vaccines alone. While vaccines play an ...

Under the plans, CEPI has committed up to $50 million to US-based Moderna for preclinical development and Phase 1 clinical ...

The fast-growing Ebola outbreak in the Democratic Republic of Congo came to the world’s attention only a little more than a week ago and is already the third-largest on record. But it’s the 17th ...

A vaccine won’t be coming soon to help quell the Ebola outbreak raging through the Democratic Republic of Congo. There are no existing vaccines targeted to the species of Ebola that is already ...

Supported by funding from the Coalition for Epidemic Preparedness Innovations (CEPI), the collaboration aims to rapidly ...

At least 452 confirmed cases and 82 deaths have been reported so far in the Democratic Republic of Congo due to the recent ...

While vaccines play an important role in reducing the spread of disease, infectious disease outbreaks have historically been ...